Monsanto has announced a nationwide proposed class settlement to resolve Roundup claims alleging non-Hodgkin lymphoma injuries. The proposed settlement is the second since their initial proposed settlement in 2020 and would include the element of a long-term compensation program providing funding for up to 21 years addressing both current and future claimants. According to Bayer, “the long-term payment stream will provide the company with …
